These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37813242)

  • 1. Steatotic liver disease phenotypes in the United States: The impact of alcohol consumption assessment.
    Ciardullo S; Perseghin G
    J Hepatol; 2024 May; 80(5):e203-e204. PubMed ID: 37813242
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study.
    Israelsen M; Torp N; Johansen S; Hansen CD; Hansen ED; Thorhauge K; Hansen JK; Villesen I; Bech K; Wernberg C; Andersen P; Lindvig KP; Tsochatzis EA; Thiele M; Rinella ME; Krag A;
    Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):218-228. PubMed ID: 38218202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between alcohol consumption and hepatic steatosis in the USA.
    Niezen S; Trivedi HD; Mukamal KJ; Jiang ZG
    Liver Int; 2021 Sep; 41(9):2020-2023. PubMed ID: 34297882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating the new nomenclature of steatotic liver disease in patients with excessive alcohol intake.
    Wu Y; Fang F
    Lancet Gastroenterol Hepatol; 2024 May; 9(5):409. PubMed ID: 38604196
    [No Abstract]   [Full Text] [Related]  

  • 5. Alcohol consumption appears to protect against non-alcoholic fatty liver disease.
    Moriya A; Iwasaki Y; Ohguchi S; Kayashima E; Mitsumune T; Taniguchi H; Ikeda F; Shiratori Y; Yamamoto K
    Aliment Pharmacol Ther; 2011 Feb; 33(3):378-88. PubMed ID: 21118396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validating the new nomenclature of steatotic liver disease in patients with excessive alcohol intake - Authors' reply.
    Israelsen M; Rinella ME; Krag A
    Lancet Gastroenterol Hepatol; 2024 May; 9(5):409-410. PubMed ID: 38604197
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of past and present alcohol use in steatotic liver disease.
    Åberg F
    Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):188-189. PubMed ID: 38218201
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of increased alcohol consumption during COVID-19 pandemic on alcohol-associated liver disease: A modeling study.
    Julien J; Ayer T; Tapper EB; Barbosa C; Dowd WN; Chhatwal J
    Hepatology; 2022 Jun; 75(6):1480-1490. PubMed ID: 34878683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Alcohol Consumption and Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Alcohol Flushing Response in Men: The Korea National Health and Nutrition Examination Survey 2019-2021.
    Kang DE; Oh SN
    Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol Intake Thresholds Among Individuals With Steatotic Liver Disease.
    Yeo YH; Zhu Y; Arab JP; Ni W; Xu X; Shi J; Li J
    JAMA Netw Open; 2023 Dec; 6(12):e2347548. PubMed ID: 38095900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.
    Younossi ZM; Stepanova M; Ong J; Yilmaz Y; Duseja A; Eguchi Y; El Kassas M; Castellanos-Fernandez M; George J; Jacobson IM; Bugianesi E; Wong VW; Arrese M; de Ledinghen V; Romero-Gomez M; Mendez-Sanchez N; Ahmed A; Wong R; Papatheodoridis G; Serfaty L; Younossi I; Nader F; Ziayee M; Afendy A;
    Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1625-1633.e1. PubMed ID: 30476585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in Nonabstinent WHO Drinking Risk Levels and Change in Risk for Liver Disease and Positive AUDIT-C Scores: Prospective 3-Year Follow-Up Results in the U.S. General Population.
    Knox J; Wall M; Witkiewitz K; Kranzler HR; Falk D; Litten R; Mann K; O'Malley SS; Scodes J; Anton R; Hasin DS;
    Alcohol Clin Exp Res; 2018 Nov; 42(11):2256-2265. PubMed ID: 30204248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of alcohol-related cirrhosis in the next decade: estimates based on current epidemiological trends in the United States.
    Guirguis J; Chhatwal J; Dasarathy J; Rivas J; McMichael D; Nagy LE; McCullough AJ; Dasarathy S
    Alcohol Clin Exp Res; 2015 Nov; 39(11):2085-94. PubMed ID: 26500036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between alcohol consumption and clinical manifestation of patients with fatty liver: a single-center study.
    Wang XF; Yue M
    Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):276-9. PubMed ID: 21669571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U.S. mortality from liver cirrhosis and alcoholic liver disease in 1999-2004: regional and state variation in relation to per capita alcohol consumption.
    Polednak AP
    Subst Use Misuse; 2012 Feb; 47(3):202-13. PubMed ID: 22217123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drinking despite health problems among individuals with liver disease across the United States.
    Elliott JC; Stohl M; Hasin DS
    Drug Alcohol Depend; 2017 Jul; 176():28-32. PubMed ID: 28514693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health risks and benefits of alcohol consumption.
    Alcohol Res Health; 2000; 24(1):5-11. PubMed ID: 11199274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease.
    VanWagner LB; Ning H; Allen NB; Ajmera V; Lewis CE; Carr JJ; Lloyd-Jones DM; Terrault NA; Siddique J
    Gastroenterology; 2017 Nov; 153(5):1260-1272.e3. PubMed ID: 28802566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimizing Risks of Liver Transplantation With Steatotic Donor Livers by Preferred Recipient Matching.
    Jackson KR; Motter JD; Haugen CE; Long JJ; King B; Philosophe B; Massie AB; Cameron AM; Garonzik-Wang J; Segev DL
    Transplantation; 2020 Aug; 104(8):1604-1611. PubMed ID: 32732837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
    Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
    Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.